OptiBiotix Health's revenue for the
six
months ended in Jun. 2023 was €0.41 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.80 Mil.
OptiBiotix Health's Revenue per Share for the
six
months ended in Jun. 2023 was €0.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.01.
Warning Sign:
OptiBiotix Health PLC revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of OptiBiotix Health was -46.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -5.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 30.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 12 years, OptiBiotix Health's highest 3-Year average Revenue per Share Growth Rate was 125.70% per year. The lowest was -5.90% per year. And the median was 58.70% per year.
OptiBiotix Health Revenue Historical Data
The historical data trend for OptiBiotix Health's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OptiBiotix Health's Revenue
For the Biotechnology subindustry, OptiBiotix Health's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptiBiotix Health's Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Revenue distribution charts can be found below:
* The bar in red indicates where OptiBiotix Health's Revenue falls into.
OptiBiotix Health Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.80 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OptiBiotix Health (FRA:OB3) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
OptiBiotix Health Revenue Related Terms
Thank you for viewing the detailed overview of OptiBiotix Health's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:OB3 has been successfully added to your 